Martin Shkreli resigns as Turing CEO day after his arrest

TRENTON, N.J. -- The pharmaceutical executive reviled for price-gouging resigned Friday as head of the drugmaker Turing Pharmaceuticals, a day after being arrested on charges of securities fraud related to a company he previously ran.

See Full Article

Martin Shkreli, whose arrest delighted countless people appalled by his unapologetic stance after hiking the price of a life-saving drug by 5,000 per cent, is being replaced on an interim basis by Ron Tilles, according to a statement issued Friday by Turing, which is privately held.

Tilles has been chairman of Turing's board of directors since the company was founded late last year. Turing said that Tilles will continue to hold the board chairman position as well. He has worked at numerous private equity and venture capital firms in the pharmaceutical and medical device industries over the last two decades.

Shkreli, a 32-year-old former hedge fund manager, has become the "most hated man in America," according to some headline writers, for jacking up the price of Daraprim, the only approved drug for a life-saving parasitic infection called toxoplasmosis, from $13.50 to $750 per pill. He did so shortly after Turing acquired rights to sell the pill in the U.S., paying another company $55 million for it.

On Thursday, federal prosecutors said that between 2009 and 2014, Shkreli lost some of his hedge fund investors' money through bad trades, then looted Retrophin, a pharmaceutical company where he was CEO, for $11 million to pay back his disgruntled clients.

Shkreli, a flagrant self-promoter who recently said he should have hiked the price of Daraprim even more, was paraded in handcuffs by the FBI after his arrest. Photos of him, wearing a grey hoodie as he was escorted by authorities, spread on the Internet like wildfire, generating social media posts celebrating his apparent fall. The news -- unrelated to his actions at Turing -- delighted patients, advocacy groups and average Joes who found his price-gouging despicable.

Shkreli pleaded not guilty to charges of securities fraud and conspiracy, which carry a sentence of up to 20 years in prison if he's convicted. He was released on $5 million bail.

Turing, which has offices in New York and Zug, Switzerland, said Tilles has worked with several securities firms, starting with Merrill Lynch in 1985.

In the company's statement, Tilles said he's excited by the chance to guide Turing and that it's "committed to ensuring that all patients have ready and affordable access to Daraprim" and a second drug, Vecamyl, a pill for treating high blood pressure.

Tilles also thanked Shkreli "for helping us build Turing Pharmaceuticals into the dynamic research-focused company it is today," a reference to Shkreli's after-the-fact claim that he needed to raise Daraprim's price so much to fund research on other drugs.

Shkreli recently became the CEO of a second company, KaloBios Pharmaceuticals, Inc., based in South San Francisco, California. There's no word yet on whether he'll remain at the helm there.



Advertisements

Latest Economic News

  • Couillard says he is open to advancing Montreal's subway contract to Bombardier

    Economic CTV News
    Quebec Premier Philippe Couillard is suggesting he's open to giving Bombardier a contract to replace Montreal's subway cars in order to stave off potential job losses at the company. Couillard said today during an economic mission to Washington D.C. Source
  • Pension fund manager OMERS earns 11.5 per cent return after all expenses in 2017

    Economic CTV News
    TORONTO -- Pension fund manager OMERS earned an investment return of 11.5 per cent after all expenses last year, topping the 10.3 per cent result it posted in 2016. The defined-benefit pension plan for Ontario's municipal employees said all of its major asset classes performed well for the year. Source
  • Ottawa vows legislation allowing firms to settle corporate corruption

    Economic CTV News
    OTTAWA -- The Canadian government is vowing to introduce legislation for corporate wrongdoing that could help SNC-Lavalin Group Inc. address criminal charges. The government says deferred prosecution agreements (DPA), which were called for in public consultations last fall, will be another tool used by judges to hold companies accountable. Source
  • TD Bank stops allowing customers to use credit cards to buy cryptocurrency

    Economic CTV News
    TORONTO -- TD Bank says it is taking a pause on allowing customers to use its credit cards to buy cryptocurrency. The big bank says it made the decision to conduct a review and assessment of the evolving market. Source
  • Auto sales to dip in most provinces, led by Ontario's 3.1% drop, Scotiabank says

    Economic CBC News
    Scotiabank says that slower job creation and weaker gains in household wealth will likely contribute to softer Canadian sales of cars and light trucks this year. That would put an end to a five-year string of growth that included a record high 2.04 million vehicles sold in 2017. Source
  • Auto sales to dip in most provinces: Scotiabank

    Economic CTV News
    TORONTO -- Scotiabank says that slower job creation and weaker gains in household wealth will likely contribute to softer Canadian sales of cars and light trucks this year. That would put an end to a five-year string of growth that included a record high 2.04 million vehicles sold in 2017. Source
  • Inflation cools to 1.7 per cent, but underlying rate continues to heat up

    Economic CTV News
    OTTAWA -- The annual pace of inflation cooled to 1.7 per cent last month -- but rising prices underneath the turbulence of this headline number suggest the Bank of Canada is unlikely to veer from its interest-rate hiking path. Source
  • Defunct Ontario mining company fined $1.3 million in 2014 worker deaths

    Economic CTV News
    The Ontario government says a now-bankrupt mining company has been fined $1.3 million in connection with the deaths of two workers in 2014. The Ministry of Labour says First Nickel Inc., was convicted of six charges under the province's Occupational Health and Safety Act and mining regulations, after two workers were killed by falling material at the Lockerby Mine in Chelmsford, Ont. Source
  • General Mills buying Blue Buffalo Pet Products for $8B US

    Economic CBC News
    Cheerios cereal maker General Mills Inc. will buy Blue Buffalo Pet Products Inc. for nearly $8 billion US, seeking to tap burgeoning demand for natural pet food and offset falling sales for processed items. The acquisition announced Friday is the latest by a major food company seeking to expand in faster growing areas such as pet- and organic-food amid falling demand for established brands. Source
  • RBC hikes dividend as flat first-quarter profit still beats expectations

    Economic CBC News
    RBC's increase to its common share dividend came as the lender saw strong results across its divisions for the quarter ended Jan. 31, but also recorded a writedown due to U.S. Source